mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c00774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von Radhika Joshi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan 304022, India. Hauptthemen laut MEDLINE: Drug Delivery Systems, RNA, Messenger. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 437 Literaturangaben. Gefördert von: Ministry of Higher Education, Science, Research and Innovation, Thailand.
Abstract (Originalsprache)
mRNA-based therapeutics represent a major advancement in modern medicine, offering programmable and nonintegrating treatment options for infectious diseases, malignancies, and hereditary disorders. This review addresses the chronological evolution, structural optimization, and delivery challenges of mRNA drugs, highlighting developments such as nucleoside modifications and lipid nanoparticle (LNP) platforms that improve the stability and promote cellular entry. Comparative analysis highlights the benefits of mRNA over DNA-, siRNA-, and protein-based medicine in safety, scalability, and rapid rearrangement. Applications vary from COVID-19 vaccines to individualized cancer immunotherapy and protein replacement strategies. New methods, including self-amplifying mRNA (saRNA), CRISPR-Cas9 gene editing, and tissue-specific delivery systems, enhance the therapeutic potential. While mRNA technology faces challenges in terms of immunogenicity, multiple dosing, and durability of safety considerations, it offers unparalleled precision, transient expression, and swift manufacturability. This review emphasizes the comparative design principles of mRNA delivery systems, bridging formulation innovation with translational biomedical applications. By integrating lipid-based and nonlipid nanocarrier insights, it highlights critical advances shaping next-generation mRNA therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan 304022, India.
- Department of Bioscience & Biotechnology, Banasthali Vidyapith, Banasthali, Rajasthan 304022, India.
- Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat 394601, India.
- Department of Pharmaceutics, Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Vadodara, Gujarat 391760, India.
- Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India.
- Department of Manufacturing Pharmacy, College of Pharmacy, Rangsit University, Pathum, Thani 12000, Thailand.
ORCID-Profile: Swapnil Sharma, Devesh U Kapoor, Pornsak Sriamornsak
Förderung
- Ministry of Higher Education, Science, Research and Innovation, Thailand
Zitieren
APA
Joshi, R., Sharma, S., Kapoor, D. U., Prajapati, B. G., Huanbutta, K., & Sriamornsak, P. (2026). mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c00774
Vancouver
Joshi R, Sharma S, Kapoor DU, Prajapati BG, Huanbutta K, Sriamornsak P. mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c00774
BibTeX
@article{Joshi2026,
author = {Joshi, Radhika and Sharma, Swapnil and Kapoor, Devesh U and Prajapati, Bhupendra G and Huanbutta, Kampanart and Sriamornsak, Pornsak},
title = {mRNA-Based Therapeutics: Advances in Drug Delivery, Comparative Innovations, and Biomedical Applications},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c00774}
}
EUVIMED